Corridome

Covetrus

Sale Life Sciences & Pharma May 25, 2022

From an SEC filing dated May 25, 2022

  1. Covetrus agreed to be sold to Clayton, Dubilier & Rice, announced on May 25, 2022.

    8-K
  2. Goldman Sachs & Co.firm and Lincoln Internationalfirm advised the seller.

    8-K
  3. The filing puts the value at $4B.

    8-K
  4. Goldman Sachs & Co.firm also worked on ADT Incdeal, on Oct 29, 2026.

    8-K

At a glance

Who was on each side

Seller's adviserGoldman Sachs & Co.

Seller's adviserLincoln International

The companyCovetrus$4Benterprise valueMay 25, 2022

BuyerClayton, Dubilier & Rice

InvestorTPG Capital

Also on the deal: BMO Capital Markets (lender), Deutsche Bank Securities (lender), Mizuho Securities USA (lender), UBS Investment Bank (lender)

Each party is named in the sources beside the statement

Parties

first 2 of 8

PartyRoleSource
Clayton, Dubilier & RiceBuyer8-K
TPG CapitalInvestor8-K

6 more parties

Sign up free to see the first 5, or become a member to see all 8.

Sign up freeBecome a member

Value

KindAmountBasisSource
Disclosed$4Benterprise value8-K

More deals

first 2 of 7

DateDealFirmsSource
Oct 29, 2026ADT Inc · SaleThrive Capital, Citigroup Global Markets8-K
Oct 29, 2026Maplebear Inc · SaleGoldman Sachs & Co., Centerview Partners8-K

5 more deals

Deals with Goldman Sachs & Co. and Lincoln International.

Sign up free to see the first 5, or become a member to see all 7.

Sign up freeBecome a member

On file

Date as stated
May 25, 20228-K
Filed by
Covetrus, Inc.8-K
Status
Completed8-K